GLENMARK PHARMACEUTICALS
|
GLENMARK PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹1,985 Cr | ₹1,399 Cr | ₹569 Cr | ₹868 Cr | ₹1,441 Cr |
| Adjustment | ₹2,690 Cr | ₹947 Cr | ₹1,010 Cr | ₹1,472 Cr | ₹787 Cr |
| Changes In working Capital | ₹-447 Cr | ₹-2,494 Cr | ₹-797 Cr | ₹-1,074 Cr | ₹-561 Cr |
| Cash Flow after changes in Working Capital | ₹4,228 Cr | ₹-147 Cr | ₹782 Cr | ₹1,266 Cr | ₹1,667 Cr |
| Cash Flow from Operating Activities | ₹3,445 Cr | ₹-828 Cr | ₹-265 Cr | ₹625 Cr | ₹1,109 Cr |
| Cash Flow from Investing Activities | ₹-1,283 Cr | ₹2.09 Cr | ₹4,561 Cr | ₹-528 Cr | ₹-333 Cr |
| Cash Flow from Financing Activities | ₹-2,709 Cr | ₹787 Cr | ₹-3,906 Cr | ₹-77 Cr | ₹-520 Cr |
| Net Cash Inflow / Outflow | ₹-547 Cr | ₹-38 Cr | ₹389 Cr | ₹19 Cr | ₹255 Cr |
| Opening Cash & Cash Equivalents | ₹1,676 Cr | ₹1,658 Cr | ₹1,443 Cr | ₹1,411 Cr | ₹1,138 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | ₹0.67 Cr | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | ₹-192 Cr | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹46 Cr | ₹56 Cr | ₹18 Cr | ₹12 Cr | ₹18 Cr |
| Closing Cash & Cash Equivalent | ₹1,175 Cr | ₹1,676 Cr | ₹1,658 Cr | ₹1,443 Cr | ₹1,411 Cr |
Compare Cashflow Statement of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹64,915.9 Cr | 5.4% | -3.5% | 22.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 5.4% |
-3.5% |
22.3% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses